GenomeQuest Inc. today announced the appointment of Robert Hoyt as an independent director of the firm, effective immediately. Mr. Hoyt’s appointment expands the Board to six directors.
“Bob’s enormous success as a B2B vertical search pioneer will add a critical perspective to our Board of Directors,” said Richard Resnick, Director and CEO. “We are very excited about his future contribution as a director and believe his counsel will be extremely valuable as GenomeQuest continues to expand its life science information business.”
Help employers find you! Check out all the jobs and post your resume.
